Hospira Vinorelbine Tartrate10 mg/1 mL Injection Vial

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

vinorelbine tartrate, Quantity: 13.85 mg/mL (Equivalent: vinorelbine, Qty 10 mg/mL)

제공처:

Hospira Australia Pty Ltd

INN (International Name):

Vinorelbine tartrate

약제 형태:

Injection

구성:

Excipient Ingredients: water for injections

관리 경로:

Intravenous

패키지 단위:

1 x 1 mL vial

수업:

Medicine Listed (Export Only)

처방전 유형:

Not scheduled. Not considered by committee

치료 징후:

Vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In stage III NSCLC, Vinorelbine is indicated with in combination with cisplatin.

제품 요약:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

승인 상태:

Listed (Export Only)

승인 날짜:

2008-05-05